Daymark Wealth Partners LLC Boosts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Daymark Wealth Partners LLC boosted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 31.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,703 shares of the company's stock after purchasing an additional 890 shares during the quarter. Daymark Wealth Partners LLC's holdings in HCA Healthcare were worth $1,280,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare during the 1st quarter valued at $28,000. Whipplewood Advisors LLC bought a new position in HCA Healthcare in the fourth quarter valued at approximately $31,000. Tidemark LLC acquired a new stake in shares of HCA Healthcare in the 4th quarter valued at $36,000. ORG Partners LLC raised its holdings in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock worth $38,000 after buying an additional 86 shares in the last quarter. Finally, Legacy Investment Solutions LLC grew its position in HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after acquiring an additional 95 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In related news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at $4,670,420.72. This trade represents a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.30% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on HCA. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Baird R W downgraded HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. Wells Fargo & Company raised HCA Healthcare from an "underweight" rating to an "equal weight" rating and upped their price objective for the company from $320.00 to $385.00 in a research note on Thursday, May 29th. Finally, Robert W. Baird restated a "neutral" rating and issued a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $394.33.

HCA Healthcare Stock Up 1.2%

Shares of HCA Healthcare stock traded up $4.69 during trading on Friday, reaching $382.35. 195,622 shares of the company traded hands, compared to its average volume of 1,470,728. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.19 and a quick ratio of 1.06. The firm has a market capitalization of $91.98 billion, a PE ratio of 16.99, a P/E/G ratio of 1.29 and a beta of 1.49. The company has a 50 day moving average price of $365.66 and a 200-day moving average price of $336.33.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same quarter last year, the firm posted $5.36 earnings per share. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.75%. HCA Healthcare's payout ratio is 12.81%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.